A hearing-loss association is only as clear as its exposure and outcome definitions. A 2021 analysis of US survey data found an association with reported methamphetamine use, but it did not establish that a recent dose caused sudden deafness. The audiometry definitions and the regression tables are essential to interpreting the finding.
What did “methamphetamine use” mean?
Lin and colleagues analyzed 1,772 adults aged 20–59 from NHANES 2011–2012. Their drug-specific table included 209 participants reporting ever using methamphetamine and 1,275 nonusers of the studied illicit drugs. This was a cross-sectional comparison, not follow-up after a controlled dose.
Ever-use can encompass very different histories. It does not locate exposure immediately before an audiogram, distinguish a single episode from prolonged use, or supply the route and dose that preceded a particular auditory change. Those missing links prevent an exposure-history category from functioning as a timeline of injury.
What counted as hearing loss?
The study used pure-tone air-conduction averages of at least 15 dB at 0.5, 1 and 2 kHz for low-frequency loss, or 3, 4, 6 and 8 kHz for high-frequency loss. Either category met its overall endpoint.
This operational definition is broader than a claim of profound bilateral sensorineural deafness. A case review should compare the actual audiogram and diagnostic assessment with the study’s criterion. A shared label does not make two outcomes identical in severity, anatomical origin or clinical significance.
Which adjusted association concerned methamphetamine?
Table 4 reported an adjusted overall hearing-loss odds ratio of 1.54 (95% confidence interval 1.05–2.27) for methamphetamine ever-use. Its adjusted frequency-specific estimates crossed one: 1.08 (0.74–1.57) for low-frequency and 1.43 (0.98–2.11) for high-frequency loss.
The overall association does not justify describing every component as statistically significant. Nor is the odds ratio an individual’s probability of hearing loss or a percentage of hearing capacity lost. The interval should remain attached to the estimate rather than being replaced by the point estimate alone.
Why consult the table rather than repeat the abstract?
For the combined illicit-drug group, the abstract labels an overall odds ratio of 1.69 as adjusted, whereas Table 2 identifies 1.69 as crude and 1.38 as adjusted. The drug-specific methamphetamine estimate above comes from Table 4.
This distinction matters when citing the paper. A combined-drug estimate should not be substituted for a methamphetamine-specific estimate. An unadjusted result also should not acquire the authority of an adjusted analysis through a summary-label error.
Does the study identify a toxic mechanism?
Its adjustment set included age, sex, race, hypertension, ear infection and diabetes. Exposure was questionnaire-based. The design could not determine causal direction.
A defensible individual explanation still requires the timing and pattern of hearing change, relevant exposure history and competing causes. The study contributes population-level observational evidence; it does not establish a diagnostic test for methamphetamine injury, predict reversibility, or set a dose threshold. This article interprets historical evidence rather than recommending clinical management.
Source
Lin PT et al. Illegal Drug Use and Risk of Hearing Loss in the United States: A National Health and Nutrition Examination Survey. International Journal of Environmental Research and Public Health. 2021;18(22):11945. doi:10.3390/ijerph182211945. Full text. Human cross-sectional analysis.